Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 6
2009 4
2011 2
2012 3
2013 1
2014 2
2015 1
2016 3
2018 3
2019 7
2020 8
2021 13
2022 17
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Preservation of memory B cell homeostasis in an individual producing broadly neutralising antibodies against HIV-1.
Griffith S, Muir L, Suchanek O, Hope J, Pade C, Gibbons JM, Tuong ZK, Fung A, Touizer E, Rees-Spear C, Nans A, Roustan C, Alguel Y, Fink D, Orkin C, Deayton J, Anderson J, Gupta RK, Doores KJ, Cherepanov P, McKnight Á, Clatworthy M, McCoy LE. Griffith S, et al. Among authors: gibbons jm. bioRxiv [Preprint]. 2024 Feb 6:2024.02.05.578789. doi: 10.1101/2024.02.05.578789. bioRxiv. 2024. PMID: 38370662 Free PMC article. Preprint.
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.
Abhishek A, Peckham N, Pade C, Gibbons JM, Cureton L, Francis A, Barber V, Williams JAE, Appelbe D, Eldridge L, Julier P, Altmann DM, Bluett J, Brooks T, Coates LC, Rombach I, Semper A, Otter A, Valdes AM, Nguyen-Van-Tam JS, Williams HC, Boyton RJ, McKnight Á, Cook JA; VROOM study investigators. Abhishek A, et al. Among authors: gibbons jm. Lancet Rheumatol. 2024 Feb;6(2):e92-e104. doi: 10.1016/S2665-9913(23)00298-9. Epub 2023 Dec 12. Lancet Rheumatol. 2024. PMID: 38267107 Free article. Clinical Trial.
Curbside particulate matter and susceptibility to SARS-CoV-2 infection.
Miyashita L, Foley G, Semple S, Gibbons JM, Pade C, McKnight Á, Grigg J. Miyashita L, et al. Among authors: gibbons jm. J Allergy Clin Immunol Glob. 2023 Jul 8;2(4):100141. doi: 10.1016/j.jacig.2023.100141. eCollection 2023 Nov. J Allergy Clin Immunol Glob. 2023. PMID: 37781647 Free PMC article.
Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity.
Altmann DM, Reynolds CJ, Joy G, Otter AD, Gibbons JM, Pade C, Swadling L, Maini MK, Brooks T, Semper A, McKnight Á, Noursadeghi M, Manisty C, Treibel TA, Moon JC; COVIDsortium investigators; Boyton RJ. Altmann DM, et al. Among authors: gibbons jm. Nat Commun. 2023 Aug 23;14(1):5139. doi: 10.1038/s41467-023-40460-1. Nat Commun. 2023. PMID: 37612310 Free PMC article.
Behçet's patients' response to COVID-19 vaccination.
Gokani B, Sacoor S, Leisegang GR, Ogunkolade W, Bibi A, Grigoriadou S, Pade C, Gibbons J, Senusi A, Fortune F. Gokani B, et al. Among authors: gibbons j. Clin Immunol. 2023 Oct;255:109700. doi: 10.1016/j.clim.2023.109700. Epub 2023 Jul 22. Clin Immunol. 2023. PMID: 37482118
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection.
Milighetti M, Peng Y, Tan C, Mark M, Nageswaran G, Byrne S, Ronel T, Peacock T, Mayer A, Chandran A, Rosenheim J, Whelan M, Yao X, Liu G, Felce SL, Dong T, Mentzer AJ, Knight JC, Balloux F, Greenstein E, Reich-Zeliger S, Pade C, Gibbons JM, Semper A, Brooks T, Otter A, Altmann DM, Boyton RJ, Maini MK, McKnight A, Manisty C, Treibel TA, Moon JC; COVIDsortium Investigators; Noursadeghi M, Chain B. Milighetti M, et al. Among authors: gibbons jm. iScience. 2023 Jun 16;26(6):106937. doi: 10.1016/j.isci.2023.106937. Epub 2023 May 22. iScience. 2023. PMID: 37275518 Free PMC article.
COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors.
Milojkovic D, Reynolds CJ, Sandoval DM, Pieper FP, Liu S, Pade C, Gibbons JM, McKnight Á, Loaiza S, Palanicawander R, Innes AJ, Claudiani S, Apperley JF, Altmann DM, Boyton RJ. Milojkovic D, et al. Among authors: gibbons jm. Leukemia. 2023 Jan;37(1):244-247. doi: 10.1038/s41375-022-01787-8. Epub 2022 Dec 17. Leukemia. 2023. PMID: 36528708 Free PMC article. No abstract available.
Neighborhood Factors Associated with COVID-19 Cases in California.
Oh DL, Meltzer D, Wang K, Canchola AJ, DeRouen MC, McDaniels-Davidson C, Gibbons J, Carvajal-Carmona L, Nodora JN, Hill L, Gomez SL, Martinez ME. Oh DL, et al. Among authors: gibbons j. J Racial Ethn Health Disparities. 2023 Dec;10(6):2653-2662. doi: 10.1007/s40615-022-01443-y. Epub 2022 Nov 14. J Racial Ethn Health Disparities. 2023. PMID: 36376642 Free PMC article.
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection.
Captur G, Moon JC, Topriceanu CC, Joy G, Swadling L, Hallqvist J, Doykov I, Patel N, Spiewak J, Baldwin T, Hamblin M, Menacho K, Fontana M, Treibel TA, Manisty C, O'Brien B, Gibbons JM, Pade C, Brooks T, Altmann DM, Boyton RJ, McKnight Á, Maini MK, Noursadeghi M, Mills K, Heywood WE; UK COVIDsortium Investigators. Captur G, et al. Among authors: gibbons jm. EBioMedicine. 2022 Nov;85:104293. doi: 10.1016/j.ebiom.2022.104293. Epub 2022 Sep 28. EBioMedicine. 2022. PMID: 36182629 Free PMC article.
64 results